Walleye Capital LLC Bausch Health Companies Inc. Transaction History
Walleye Capital LLC
- $38.9 Billion
- Q4 2024
A detailed history of Walleye Capital LLC transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 2,200 shares of BHC stock, worth $15,796. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,200
Previous 3,767
41.6%
Holding current value
$15,796
Previous $30,000
43.33%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding BHC
# of Institutions
270Shares Held
252MCall Options Held
5.12MPut Options Held
9.43M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$249 Million3.8% of portfolio
-
Goldentree Asset Management LP New York, NY27.5MShares$198 Million16.77% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$190 Million12.9% of portfolio
-
National Bank Of Canada15.4MShares$111 Million0.17% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$93.3 Million0.23% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.6B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...